Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition). [PDF]
Mo X +49 more
europepmc +1 more source
Juvenile idiopathic arthritis or skeletal dysplasia: first case report of camptodactyly-arthropathy-coxa vara-pericarditis from Iran. [PDF]
Shashaani N +3 more
europepmc +1 more source
Engaging Adolescents With Chronic Illness in Patient-Education: The Adolescent's Perception. [PDF]
Morin MP +6 more
europepmc +1 more source
Predictors of relapse after withdrawing biotherapies in children with inactive juvenile idiopathic arthritis: a retrospective cohort study of the JIR cohort. [PDF]
Jallot V +6 more
europepmc +1 more source
JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. [PDF]
Almerri S +3 more
europepmc +1 more source
Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21. [PDF]
Akay N +5 more
europepmc +1 more source
When to address fatigue in juvenile idiopathic arthritis during clinical visits based on the JAMAR. [PDF]
Vroegindeweij A +6 more
europepmc +1 more source
Anti-Nuclear Antibody Staining Patterns in Juvenile Idiopathic Arthritis: Association of AC-1 Pattern and Elevated Titers with Uveitis. [PDF]
Koru L +11 more
europepmc +1 more source
The impact of juvenile idiopathic arthritis on psychosocial outcomes: a systematic review and meta-analysis. [PDF]
Richmond B +6 more
europepmc +1 more source
Methotrexate use in juvenile idiopathic arthritis and its impact on growth plate development: A prospective observational cohort study. [PDF]
Ahirwar S +6 more
europepmc +1 more source

